Obesity Surgery Device Market - Forecast(2024 - 2030)

Report Code: HCR 0844 Report Format: PDF + Excel

Obesity Surgery Device Market Overview

Obesity Surgery Device Market Size is estimated to reach $3.8 billion by 2027. Furthermore, it is poised to grow at a CAGR of 5.6% over the forecast period of 2022-2027. According to World Health Organization, overweight and obesity are defined as abnormal or excessive fat accumulation that poses a health concern. Overweight is defined as a BMI of 25 or higher, and obesity is defined as a BMI of 30 or higher. Obesity has become one of the most serious health problems in the world in recent years. It arises primarily as a result of increased consumption of high-fat foods and decreasing physical activity among huge populations; hence need for obesity surgery is raised. Obesity surgery is a type of weight-loss surgery that involves the stomach and intestines. Some of the operations available include gastric bypass, gastric bands, stomach shortening, stomach staples, intragastric balloons, and implantable gastric stimulation used for obesity surgery. This technique is designed to address a comorbid disease that is linked to morbid obesity. Obesity surgery devices work by limiting the amount of food that can be absorbed by the stomach and the nutrients that can be absorbed by the intestinal system. Obesity surgery is a safe and effective therapy option for people who are severely obese, as well as individuals who have obesity and other obesity-related illnesses. As per WHO data, obesity affects 650 million persons over the age of 18 all over the world every year. Due to increased obesity, a hike in spending on obesity surgery propels the market for Obesity Surgery devices over the forecast period 2022–2027.

Obesity Surgery Device Market Report Coverage

The report: “Obesity Surgery Device Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Obesity Surgery Device Market.

By Procedure: Sleeve Gastrectomy, Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch.
By Device: Intragastric Balloons, Gastric electrical stimulators, Gastric bands, Staples, Suturing Devices, Trocars, and Others.
By Application: Weight Loss, Hereditary Disease, and Others.
By End User: Bariatric Surgery Clinics, and Others. 
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America held a dominant market share in the year 2021, owing to the increase in obesity surgery in the region and the presence of key market players. The government initiative for awareness about obesity and various action plans to minimize it, along with the popularity of non-invasive surgery and device drive the market.
  • Obesity Surgery Device Market is predicted to increase owing to the increasing number of cardiac cases hence hectic lifestyle, consumption of unhealthy food, and addiction. However, the lack of medical support staff restricts the growth of the Obesity Surgery Device market over the forecast period 2022-2027.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Obesity Surgery Device Market Report.

Obesity Surgery Device Market: Market Share (%) by Region, 2021

For More Details on This Report - Request for Sample

Obesity Surgery Device Market Segmentation Analysis- By Procedure

The obesity Surgery Device Market based on the procedure can be further segmented into Sleeve Gastrectomy, Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, and Biliopancreatic Diversion with Duodenal Switch. The sleeve Gastrectomy segment held a dominant market share in the year 2021 and is expected to grow at the quickest rate between 2022 and 2027, with a CAGR of 6.5%. Sleeve Gastrectomy is highly effective for obese patients with type 2 diabetes, it cut dependency on insulin for at least three years after surgery. In June 2021, Standard Bariatrics, Inc., developed the Titan SGS, this device offers surgeons performing sleeve gastrectomy, the most common bariatric surgery for obesity, the industry’s longest continuous staple cutline of 23 centimeters. Owing to such innovation and advantages of sleeve gastrectomy patients preference, it can fuel the market for obesity surgery devices.

Obesity Surgery Device Market Segmentation Analysis- By Device

The obesity Surgery Device Market based on the Device can be further segmented into Intragastric Balloons, Gastric electrical stimulators, Gastric bands, Staples, Suturing Devices, Trocars, and Others. The Gastric band’s segment held a dominant market share in the year 2021. This is attributed to average weight loss being near about 40-50% after applying a gastric band with a low rate of postoperative complication and mortality. In this procedure, there is no need to cut the stomach or to reroute the intestine. As per The American Society for Metabolic and Bariatric Surgery (ASMBS) there were 7344 obesity surgery performed using gastric bands in 2019. Such FDA-approved procedures and the increasing prevalence of obesity creates a market for obesity surgery device.

However, Suturing Devices is expected to grow with the fastest CAGR rate of 6.3% between 2022 and 2027. Owing to the increasing number of surgeries across the world, according to the journal ‘The Lancet’ 313 million surgeries are performed every year across the world. Also, 5 billion people do not have access to safe and affordable surgical care. This creates huge scope for suturing device and propel the obesity surgery market over the forecast period. 

Obesity Surgery Device Market Segmentation Analysis- By Geography

The Obesity Surgery Device Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 35% in the year 2021. Owing to the continuous rise in the obesity rate in North America as a result of a non-active lifestyle, consumption of junk and fatty food enhance the chances of obesity. In America above 30% of adults over 18 aged are obsessed and from 9 to 12 aged students, 15% are obsessed as per data by CDC in 2020. In 2019, about 256000 obesity surgery are performed as per the American Society for Metabolic and Bariatric Surgery. An increase in the number of obese people creates scope for the obesity device market in North America. 

Furthermore, the Asia-Pacific is estimated to grow with the fastest CAGR over the forecast period 2022-2027. With increasing initiative by government and private sectors, increasing health awareness among people with better living standards drive the Asia-Pacific Obesity Surgery market. Obesity increases the chances of cardiovascular disease and diabetes in the body. With 69.2 million people suffering from diabetes, India is only second to China in the world according to the India Journal of Surgery, published in January 2022. Also, the presence of key market players like Medtronic, J&J, and Allergan; R&D, and innovations fuel market growth.

Obesity Surgery Device Market Drivers

Increase in Population Suffering From Obesity Around the Globe Drive Market.

People are living in the time-bounded professions and consume junk food or fast food which is the main reason behind adding excess weight to the body. As per world data, 13% of adults in the world are obese. 39% of adults in the world are overweight. One-in-five children and adolescents globally were overweight in 2021. Such increasing prevalence of obesity increases the risk of diseases associated with diabetes, joint pain, infertility, cardiovascular diseases, and others. As per NCBI, the number of surgery and endoluminal procedure performed in 2019 was 696,191; and in America, 580000 people undergo obesity surgery each year. WHO report says that 2.8 million people are dying as a result of obesity and overweight each year. Such increasing incidence and increasing population come under over-weight and obese drive Obesity Surgery Market.

Government Initiatives to Reduce Obesity Propel Market.

Obesity is one of the concerns that affect personal life, profession, and also the national economy as a reduced productive population. Major governments take initiative to reduce obesity, for instance, UK governments set policies for people suffering from being overweight or with obesity which include evidence-based tools and apps by National Health System, help people to make healthy food choices, and introduce new legislation such as labeling calories on food sales all over in the country and other majors. Australian government develops National Obesity Strategy for 2022 to 2032, this action plan includes 32 strategies. In 2019, to tackle child obesity Indian government established OPD for children and teenagers to control the growing problem of obesity. Indian ministry also supports the subsidy for treatment of any required surgery in a serious case. In Asia-pacific obesity cause a burden of 12.36% of healthcare expenditure. As per the CDC, the U.S healthcare system pays $147 billion per year for obesity. Such increasing initiative by governments and spending on obesity drives the Obesity surgery device market.

Obesity Surgery Device Market Challenges

Lack of Medical Support Staff is Hampering Market Growth.

The chain of hospitals, clinical laboratories, and diagnostic centers spreads all over the globe. With the increasing global population, there is an increasing load on the healthcare system to provide efficient service. Some factors slugging growth of healthcare sector such as high investment on infrastructure, equipment’s and machinery, also lack of skilled professional is one of the major challenges. According to the WHO, the number of healthcare workers around the globe would reduce by 12.9 million by 2035. The global shortage of healthcare personnel is linked to a number of factors including an aging workforce, a decline in the number of persons joining the profession, early retirements, insufficient training, and increased demands from a growing and aging population, which hamper market growth over the forecast period 2022-2027.

Obesity Surgery Device Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Obesity Surgery Device Market. The top 10- Obesity Surgery Device Market companies are:

1. TransEnterix Inc
2. Allergan Inc
3. Mediflex Surgical Products
4. Johnson and Johnson
5. Aspire Bariatrics, Inc
6. IntraPace Inc
7. Medtronic Inc
8. Cousin Biotech,
9. Spatz FGIA Inc
10. EnteroMedics Inc

Recent Developments

  • In November 2021, TransEnterix Inc announced a partnership with Amsterdam Skills Center (ASC) in Netherland for surgical training on Senhance Surgical System for European clinicians. The Senhance combines machine, vision, and learning capabilities with precision surgery in real-time.
  • In April 2021, Medtronic Inc, introduced the Medtronic Extended Infusion set first in the market, which can be worn for up to one week. This Infusion set delivers insulin from the pump to the body which manages diabetics. The set is compatible with MiniMed 600 and 700 series insulin pumps. 
  • In February 2021, Allergan Inc and PatientFi started their initial phase of the partnership. The company provides customized financing options for patients undergoing breast augmentation with the Allergan Aesthetics Natrelle line of breast implants. Partnership with PatientFi made with the vision of affordable aesthetic treatment with Allergan leading portfolio products and treatment.

Relevant Titles

Report Code: HCR 0348

Report Code: HCR 0010

Report Code: CMR 0599

For more Electronics Market reports, please click here

1. Obesity Surgery Device Market– Overview
    1.1 Definitions and Scope
2. Obesity Surgery Device Market- Executive Summary
3. Obesity Surgery Device Market - Comparative Analysis
    3.1 Company Benchmarking - Key Companies
    3.2 Global Financial Analysis - Key Companies
    3.3 Market Share Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Obesity Surgery Device Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Obesity Surgery Device Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Obesity Surgery Device Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Obesity Surgery Device Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Obesity Surgery Device Market – By Procedure
    8.1 Sleeve Gastrectomy
    8.2 Adjustable Gastric Banding
    8.3 Roux-en-Y Gastric Bypass
    8.4 Biliopancreatic Diversion with Duodenal Switch
9. Obesity Surgery Device Market – By Device
    9.1 Intragastric Balloons
    9.2 Gastric electrical stimulators
    9.3 Gastric bands
    9.4 Staples
    9.5 Suturing Devices
    9.6 Trocars
    9.7 Others
10. Obesity Surgery Device Market – By Application
    10.1 Weight Loss
    10.2 Hereditary Disease
    10.3 Others
11. Obesity Surgery Device Market – By End User
    11.1 Bariatric Surgery Clinics
    11.2 Hospitals
    11.3 Others
12. Obesity Surgery Device Market - By Geography
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Chile
        12.4.4 Colombia
        12.4.5 Rest of South America
13. Rest of the World
    13.1.1 Middle East
    13.1.2 Africa
14. Obesity Surgery Device Market - Entropy
15. Obesity Surgery Device Market – Industry/Segment Competition Landscape Premium 
    15.1 Market Share Analysis
        15.1.1 Global Market Share – Key Companies
        15.1.2 Market Share by Region – Key companies
        15.1.3 Market Share by Countries – Key Companies
    15.2 Competition Matrix
    15.3 Best Practices for Companies
16. Obesity Surgery Device Market – Key Company List by Country Premium Premium
17. Obesity Surgery Device Market - Company Analysis
    17.1 Company 1
    17.2 Company 2
    17.3 Company 3
    17.4 Company 4
    17.5 Company 5
    17.6 Company 6
    17.7 Company 7
    17.8 Company 8
    17.9 Company 9
    17.10Company 10
"*Financials for private companies would be provided on a best efforts basis*”.